At Stripe’s Sessions conference this week, Mark Zuckerberg pitched what he calls the “ultimate business machine”: a fully automated, end-to-end AI ad engine promising to replace agencies, creatives, and media buyers with a single black box. You just need to connect your bank account first. Zuckerberg claims this could be one of the most valuable […]
Meta’s speeding up the ‘Mad Men to Math Men’ pipeline Read More »
Longevity is a hot trend in Silicon Valley these days, driven by rising interest—especially among the wealthy—in preventing disease through regular testing. A new player, Biograph, has just emerged from stealth, and it’s co-founded by one of the biggest names in longevity science: Dr. Peter Attia. Attia is a Canadian-American physician best known as the
Startup co-founded by longevity guru Peter Attia emerges from stealth Read More »
OpenAI CEO Sam Altman is doubling down on Retro Biosciences, a biotech startup based in San Francisco that wants humans to live 10 years longer than what it calls a healthy human lifespan. Altman previously provided Retro Biosciences’ entire seed round of $180 million. Now, the startup is raising a $1 billion Series A that
Retro Biosciences, backed by Sam Altman, is raising $1 billion to extend human lifespan Read More »
Rare earth metals are largely unknown to the general public, but are used in a huge variety of products. The elements, including neodymium, and praesodymium, and cerium, themselves aren’t rare. But they’re concentrated in certain parts of the globe and are very challenging to refine into anything useful. Their unique electric and magnetic properties make
Alta Resource breaks down e-waste for rare earth metals that electronics need Read More »
When Valeria Kogan started her Ph.D. program in bioinformatics, the scientific field that uses computation and software to analyze biological data, in 2017, she imagined her career would always be within the fields of mathematics, medicine, or biology. But after the first AI boom in the late 2010s, she got an intriguing opportunity in a
Fermata uses computer vision to detect diseases and pests in plants Read More »
“If you build it, they won’t come,” Bison Ventures co-founder Tom Biegala said Wednesday on the Equity podcast. The phrase is an internal mantra at Bison, the early-stage venture firm betting on ‘frontier tech’ companies building in the material science, robotics, biotech, climate, and sustainability verticals; one that’s meant to dissuade founders from solving the
‘If you build it, they won’t come’: Bison Ventures founders on scaling frontier tech Read More »
IndieBio’s Bay Area incubator is about to debut its 15th cohort of biotech startups. We took special note of a few, which were making some major, bordering on ludicrous, claims that could pay off in a big way. Biotech has been creeping out in recent years to touch adjacent industries, as companies find how much
IndieBio’s SF incubator lineup is making some wild biotech promises Read More »
